510(k) K202007— LZI Oxycodone III Enzyme Immunoassay

Substantially Equivalent

Lin-Zhi International, Inc.

Clearance details

Applicant: Lin-Zhi International, Inc.
Product code: Code DJG
Advisory panel: Clinical Toxicology
Date received: 2020-07-21
Decision date: 2020-09-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Santa Clara, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.